CSHP Tracked Legislation (2017-2018)
Share |

TABLE OF CONTENTS

Support/Sponsor Legislation     Watch Legislation
AB 315- Pharmacy Benefit Management
    AB 182 - Heroin and Opioid Public Education (HOPE) Act
AB 1751- Controlled Substances: CURES database
    AB 186 - Controlled Substance: Safer Drug Consumption Program
AB 1752 - Controlled Substances: CURES database
    AB 447 - Medi-Cal Covered Benefits: Continuous Glucose Monitors
AB 1963 - Medi-Cal: Reimbursement: Opioid Addiction Treatment
    AB 587 - State Government Pharmaceuticals Procurement: Collaborative
AB 2174 - Controlled Substances: CURES Database
    AB 1753 - Controlled Substances: CURES Database
AB 2256 - Law Enforcement Agencies: Opioid Antagonist
    AB 2037- Pharmacy: Automated Drug Delivery Systems
AB 2384 - Medication-assisted Treatment
    AB 2086 - Controlled Substances: CURES Database
AB 2576 - Emergencies: Healthcare
    AB 2138 - Licensing Boards Denial of Application: Revocation or
Suspension of Licensure: Criminal Conviction
AB 2760 - Prescription Drugs: Naloxone Hydrochloride


AB 2277 - Solid Waste Facilities: Home-generated Pharmaceutical Waste: Incineration
AB 2789 - Law Enforcement Agencies: Opioid Antagonist


AB 2486 - Medi-Cal Opioid Prevention and Rehabilitation Act
AB 2941 - Health Care Coverage: State of Emergency


AB 2487 - Physicians and Surgeons: Education: Opiate-dependent Patient Treatment and Management
SB 433 - Pharmacy Emergency Medical Services Automated Drug Delivery System       AB 2624 - Prescriptions
SB 716 - California State Board of Pharmacy: Pharmacy Technician Member (CSHP Sponsored)
    AB 2653 - Health Care Coverage: Prescriptions 
SB 1254 - Hospital Pharmacies: Medication Profiles or Lists for High-risk Patients
    AB 2741 - Prescription Drugs: Opioid Medications: Minors
SB 1264 - Medi-Cal: Hypertension Medication Management Services: Advanced Practice Pharmacists (CSHP Sponsored)
    AB 2783 - Controlled Substances: Hydrocodone Combination Products: Schedules
SB 1285 - Health Care Coverage: Advanced Practice Pharmacists  
    AB 2859 - Pharmacy: Safe Storage Products
SB 1404 - Pharmacists: Exemption From Overtime Regulations
    AB 2863 - Health Care Coverage: Prescriptions
SB 1426 - Pharmacists: Authority to Prescribe and Dispense Dangerous Drugs and Devices
    AB 2874 - Health Facilities: Notice: Attorney General
Opposition Legislation
    AB 3184 - California State Board of Optometry
AB 1998 - Opioids: Prescription Limitations
    SB 43 - Antimicrobial-resistant Infection: Reporting
SB 1109 - Controlled Substances: Schedule II Drugs: Opioids
    SB 199 - The California Health Care Cost, Quality, and Equity Atlas
SB 1286 - Pharmacy Technicians
    SB 212 - Medical Waste
Chaptered Legislation     SB 320 - Public Health: Public Postsecondary Education On-campus Student Health Centers: Abortion by Medication Techniques
AB 40 - CURES Database: Health Information Technology System     SB 419 - Medical Practice: Pain Management
 AB 265 - Prescription Drugs: Prohibition on Price Discount     SB 528 - Pharmacy: Automated Drug Delivery System
AB 395 - Substance Use Treatment Providers
    SB 562 - The Healthy California Act
 AB 401 - Pharmacy: Remote Dispensing Site Pharmacy: Telepharmacy
    SB 641 - Controlled Substance Utilization Review and Evaluation System: Privacy
AB 602 - Pharmacy: Nonprescription Diabetes Test Devices
    SB 790 - Health Care Providers: Gift and Benefits
AB 1048 - Health Care: Pain Management and Schedule II Drug Descriptions
    SB 1021 - Prescription Drugs
SB 17- Health Care: Prescription Drug Costs     SB 1229 - Pharmacists: Opioid Medications: Consultation
SB 351 - Hospital Satellite Compounding Pharmacy License Requirements     SB 1240 - Prescription Drugs: CURES Database: Opioids
SB 510 - Pharmacies: Compounding     SB 1322 - Medi-Cal: Comprehensive Medication Management
Dead Legislation     SB 1373 - Opioid Addiction Prevention and Rehabilitation Act
AB 29 - Pharmacy Benefits Manager
    SB 1442 - General Acute Care Hospitals: Minimum Levels of Pharmaceutical Staff
AB 387 - Minimum Wage: Health Professionals: Interns     SB 1447 - Pharmacy: Automated Drug Delivery Systems: Licensing
AB 904 - Prescription Drugs     SB 1448 - Healing Art Licensees: Probation Status: Disclosure
AB 966 - Pupil Health: Medication Assistance    
AB 1512 - Opioid Addiction Prevention and Rehabilitation Act    
AB 1589 - Pharmacy: Pharmacist Supervision: Technicians
   
AB 1643 - Health Care for All Commission
   
 Last Updated: July 5, 2018  

 


Legislative Resources
Legend/Glossary Terms

 

 


AB 29 - Pharmacy Benefit Managers (View Bill)
Bill Author: Adrin Nazarian
CSHP Position: Dead Bill (Prev. Watch)

Bill Summary:
Current law requires a pharmacy benefit manager that reimburses a contracting pharmacy for a drug on a maximum allowable cost basis to provide the contracting pharmacy with specified information regarding the data used to determine the maximum allowable cost of a drug. This bill would require, except as provided, a pharmacy benefit manager to disclose certain information to a purchaser, including, among other things, the aggregate amount of rebates, retrospective utilization discounts, and other income that the pharmacy benefit manager would receive from a pharmaceutical manufacturer or labeler in connection with drug benefits related to the purchaser.


 

AB 40 - CURES Database: Health Information Technology System (View Bill)
Bill Author: Miguel Santiago
CSHP Position: Chaptered Bill (Prev. Support)

Bill Summary:
 Would require the Department of Justice to make the electronic history of controlled substances dispensed to an individual under a health care practitioner’s or pharmacist’s care, based on data contained in the CURES database, available to the practitioner or pharmacist, as specified. The bill would authorize a health care practitioner or pharmacist to submit a query to the CURES database through the department’s online portal or through a health information technology system if the entity operating the system can certify, among other requirements, that the system meets applicable patient privacy and information security requirements of state and federal law.


 

AB 182 - Heroin and Opioid Public Education (HOPE) Act (View Bill)
Bill Author: Marie Waldron
CSHP Position: Watch

Bill Summary:
Would require the State Department of Health Care Services, in consultation with stakeholders, to develop, coordinate, implement, and oversee a comprehensive multicultural public awareness campaign, to be known as “Heroin and Opioid Public Education (HOPE),” upon appropriation by the Legislature or receipt of state or federal grant funding, until January 1, 2023. The bill would require the HOPE program to provide for the coordinated and widespread public dissemination of individual case stories and other generalized information that focuses on, among other things, describing the effects and warning signs of heroin use and opioid medication and identifying available pathways for individuals seeking help.


 

AB 186 - Controlled Substances: Safer Drug Consumption Program (View Bill)
Bill Author: Susan Eggman
CSHP Position: Watch

Bill Summary:
Would, until January 1, 2022, authorize specified counties or cities within those counties to authorize the operation of supervised injection services programs for adults that satisfies specified requirements, including, among other things, a hygienic space supervised by health care professionals, as defined, where people who use drugs can consume preobtained drugs, sterile consumption supplies, and access to referrals to substance use disorder treatment. The bill would require any entity operating a program under its provisions to provide an annual report to the city, county, or city and county, as specified.


 

AB 265 - Prescription Drugs: Prohibition on Price Discount (View Bill)
Bill Author: Jim Wood
CSHP Position: Chaptered (Prev. Watch)

Bill Summary:
Would generally prohibit a person who manufactures a prescription drug from offering in California any discount, repayment, product voucher, or other reduction in an individual’s out-of-pocket expenses associated with his or her health insurance, health care service plan, or other health coverage, including, but not limited to, a copayment, coinsurance, or deductible, for any prescription drug if a lower cost generic drug is covered under the individual’s health insurance, health care service plan, or other health coverage on a lower cost-sharing tier that is designated as therapeutically equivalent to the prescription drug manufactured by that person or if the active ingredients of the drug are contained in products regulated by the federal Food and Drug Administration, are available without prescription at a lower cost, and are not otherwise contraindicated for the condition for which the prescription drug is approved.


 

AB 315 - Pharmacy Benefit Management (View Bill)
Bill Author: Jim Wood
CSHP Position: Support

Bill Summary:
Would require pharmacy benefit managers, as defined, to be registered with the Department of Managed Health Care, as prescribed. The bill would require the department to develop applications for the registration, and would specify certain information to be provided in those applications. The bill would authorize the department to charge a fee for registration, as specified. The bill would authorize the director of the department to suspend the registration of a pharmacy benefit manager under specified circumstances.


 

AB 387 - Minimum Wage: Health Professionals: Interns (View Bill)
Bill Author: Tony Thurmond
CSHP Position: Dead (Prev. Watch)

Bill Summary:
Current law requires the minimum wage for all industries to not be less than specified amounts to be increased from January 1, 2017, to January 1, 2022, inclusive, for employers employing 26 or more employees and from January 1, 2018, to January 1, 2023, inclusive, for employers employing 25 or fewer employees, except when the scheduled increases are temporarily suspended by the Governor, based on certain determinations. Current law defines an employer for purposes of those provisions. This bill would expand the definition of “employer” for purposes of these provisions to include a person who directly or indirectly, or through an agent or any other person, employs or exercises control over the wages, hours, or working conditions of a person engaged in a period of supervised work experience longer than 100 hours to satisfy requirements for licensure, registration, or certification as an allied health professional, as defined.


 

AB 395 - Substance Use Treatment Providers (View Bill)
Bill Author: Raul Bocanegra
CSHP Position: Chaptered (Prev. Support if amended)

Bill Summary:
Would add the use of medication-assisted treatment as an authorized service by narcotic treatment programs licensed by the State Department of Health Care Services, and would, in that regard, make legislative findings and declarations that it is in the best interest of the health and welfare of the people of this state to also coordinate medication-assisted treatments for substance use disorders.



AB 401 - Pharmacy: Remote Dispencing Site Pharmacy: Telepharmacy (View Bill)
Bill Author: Cecilia Aguiar-Curry
CSHP Position: Chaptered ( Prev. Oppose Unless Amended)

Bill Summary:
The Pharmacy Law requires the California State Board of Pharmacy, which is within the Department of Consumer Affairs, to license and regulate the practice of pharmacy, including pharmacists, pharmacy technicians, and pharmacies. This bill would require the board to issue a remote dispensing site pharmacy license to a supervising pharmacy, as defined, of a remote dispensing site pharmacy, as defined, if all the requirements for licensure are met for the purpose of increasing access to dispensing or pharmaceutical care services in the geographic area in which the remote dispensing site pharmacy is located.


 

AB 447 - Medi-Cal Covered Benefits: Continuous Glucose Monitors (View Bill)
Bill Author: Adam Gray
CSHP Position: Watch

Bill Summary:
The Medi-Cal program is, in part, governed by, and funded pursuant to, federal Medicaid program provisions. Current law provides for a schedule of covered benefits under the Medi-Cal program. This bill would, to the extent that federal financial participation is available and any necessary federal approvals have been obtained, add continuous glucose monitors and related Page 3/11 supplies required for use with those monitors to the schedule of benefits under the Medi-Cal program for the treatment of diabetes mellitus type 1 and diabetes mellitus type 2 when medically necessary, subject to utilization controls.


 

AB 587 - State Government Pharmaceuticals Procurement: Collaborative (View Bill)
Bill Author: David Chiu
CSHP Position: Watch

Bill Summary:
Current law authorizes the Department of General Services to explore additional strategies for managing prescription drug costs and investigate and implement those strategies in consultation with other specified state agencies. This bill would revise these provisions and instead require the department to convene the California Pharmaceutical Collaborative cochaired by the Deputy Director of the Procurement Division of the department and the Assistant Secretary of California Health and Human Services to address the rising cost of pharmaceuticals.


 

AB 602 - Pharmacy: Nonprescription Diabetes Test Devices (View Bill)
Bill Author: Rob Bonta
CSHP Position: Chaptered ( Prev. Watch)

Bill Summary:
The Pharmacy Law authorizes the California State Board of Pharmacy to take disciplinary action against any holder of a license who is guilty of unprofessional conduct, as described, or whose license has been issued by mistake. That law also requires the records of manufacture and of sale, acquisition, receipt, shipment, or disposition of dangerous drugs or dangerous devices to be open for inspection during business hours and preserved for at least 3 years, as specified. This bill would make it unprofessional conduct for a licensee to acquire a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test device’s manufacturer or manufacturer’s authorized distributor or to submit to specified persons a claim for reimbursement for a nonprescription diabetes test device when the licensee knew or should have known that the diabetes test device was not purchased directly from the manufacturer or from a manufacturer’s authorized distributor.


 

AB 904 -  Prescription Drugs (View Bill)
Bill Author: James Gallagher
CSHP Position: Dead (Prev. Watch)

Bill Summary:
Would declare the intent of the Legislature to enact legislation that would address high prescription drug costs. 


 

AB 966 -  Pupil Health: Medication Assistance (View Bill)
Bill Author: Ed Chau
CSHP Position: Dead (Prev. Watch)

Bill Summary:
Current law authorizes a school nurse or other designated school personnel to assist any pupil who is required to take, during the regular school day, medication prescribed for him or her by a healthcare provider, if the school district receives specified written statements from the physician and surgeon or physician assistant and from the parent, foster parent, or guardian of the pupil. This bill would make nonsubstantive changes to that provision.


 

AB 1048 -  Health Care: Pain Management and Schedule II Drug Prescriptions (View Bill)
Bill Author: Joaquin Arambula
CSHP Position: Chaptered ( Prev. Support if Amended)

Bill Summary:
 Would, beginning July 1, 2018, authorize a pharmacist to dispense a Schedule II controlled substance as a partial fill if requested by the patient or the prescriber. The bill would require the pharmacy to retain the original prescription, with a notation of how much of the prescription has been filled, the date and amount of each partial fill, and the initials of the pharmacist dispensing each partial fill, until the prescription has been fully dispensed. The bill would authorize a pharmacist to charge a professional dispensing fee to cover the actual supply and labor costs associated with dispensing each partial fill associated with the original prescription. 


 

AB 1512 - Opioid Addiction Prevention and Rehabilitation Act (View Bill)
Bill Author: Kevin Santiago
CSHP Position: Dead (Prev. Oppose Unless Amended)

Bill Summary:
Current law imposes various fees and taxes, including taxes on the privilege of engaging in certain activities. The Fee Collection Procedures Law, the violation of which is a crime, provides procedures for the collection of certain fees and surcharges. Under this bill, the Opioid Addiction Prevention and Rehabilitation Act would impose a tax on and after July 1, 2018, upon the distribution of opioids by a manufacturer to a wholesaler from the manufacturer, as those terms are defined, at the rate of $0.01 per milligram of active opioid ingredient. 


 

AB 1589 -  Pharmacy: Pharmacist Supervision: Technicians (View Bill)
Bill Author: Raul Bocanegra
CSHP Position: Dead (Prev. Watch)

Bill Summary:
Current law authorizes a pharmacy technician to perform certain tasks under the direct supervision and control of a pharmacist. Existing law prohibits a pharmacy with one pharmacist from having more than one pharmacy technician and prohibits the ratio of pharmacy technicians to any additional pharmacists from exceeding 2 to 1, except as specified. This bill would raise the limit on the number of pharmacy technicians a pharmacy with one pharmacist may have to 4 and would raise the limit on the ratio of pharmacy technicians to any additional pharmacists to 4 to 1.


 

AB 1643 - Health Care for All Commission (View Bill)
Bill Author
: Rob Bonta
CSHP Position: Dead (Prev. Support)

Bill Summary:
Current law requires health care service plans and health insurers to file specified rate information with DMHC or DOI, as applicable, for health care service plan contracts or health insurance policies in the individual or small group markets and for health care service plan contracts and health insurance policies in the large group market. This bill would require health care service plans or health insurers that file the above-described rate information to report to DMHC or DOI, on a date no later than the reporting of the rate information, specified cost information regarding covered prescription drugs, including generic drugs, brand name drugs, and specialty drugs, dispensed as provided. DMHC and DOI would be required to compile the reported information into a report for the public and legislators that demonstrates the overall impact of drug costs on health care premiums and publish the reports on their web sites by January 1 of each year. 


 

AB 1751 - Controlled substances: CURES database (View Bill)
Bill Author
: Evan Low
CSHP Position: Support

Bill Summary:
Would authorize the Department of Justice to enter into an agreement with an entity operating an interstate data share hub for the purposes of participating in interjurisdictional information sharing between prescription drug monitoring programs across state lines. The bill would require any agreement entered into by the Department of Justice for those purposes to ensure that all access to data within CURES complies with California law and meets the same patient privacy and data security standards employed and required for direct access of CURES.


 

AB 1752 - Controlled substances: CURES database (View Bill)
Bill Author
: Evan Low
CSHP Position: Support if Amended

Bill Summary:
Would add Schedule V controlled substances to the CURES database. The bill would require a dispensing pharmacy, clinic, or other dispenser to report the information required by the CURES database no more than one working day after a controlled substance is dispensed. The bill would change what information is required to be reported by deleting references to classification codes and adding the date of sale of the prescription.


 

AB 1753 - Controlled substances: CURES database (View Bill)
Bill Author
: Evan Low
CSHP Position: Watch

Bill Summary:
Current law requires prescription forms for controlled substance prescriptions to be obtained from security printers approved by the Department of Justice, as specified. Current law requires a dispensing pharmacy, clinic, or other dispenser to report specified information to the Department of Justice. This bill would, beginning January 1, 2020, require the Department of Justice to limit the number of approved printers to 3, as specified. The bill would require prescription forms for controlled substance prescriptions to have a uniquely serialized number, in a manner prescribed by the Department of Justice, and would require a printer to submit specified information to the Department of Justice for all prescription forms delivered.



AB 1963 - Medi-Cal: Reimbursement: Opioid Addiction Treatment (View Bill)
Bill Author
: Marie Waldron
CSHP Position: Support

Bill Summary:
This bill would require the department to increase the Medi-Cal provider reimbursement rates, as specified, for medication-assisted treatments, buprenorphine/naloxone combination treatment, methadone treatment, and naltrexone treatment, provided by certified providers, for opioid addiction.



AB 1998 - Opioids: Prescription Limitations (View Bill)
Bill Author
: Freddie Rodriguez
CSHP Position:Oppose

Bill Summary:
Would prohibit a prescriber from prescribing an opioid in an amount greater that the patient needs for a 3-day period unless the prescriber believes, in his or her professional judgment, that a larger prescription is needed to treat a medical condition or that a larger prescription is necessary for the treatment of chronic pain. The bill would require a prescriber who writes a prescription for an opioid that is either larger than the 3-day supply or that is the 4th prescription without the dosage decreasing to include in the patient’s record why the excess or additional prescription was needed, what other medications were considered, the patient’s injury or illness, and the milligram dosage of the prescription.



AB 2037 - Pharmacy: Automated Drug Delivery Systems (View Bill)
Bill Author
: Rob Bonta
CSHP Position: Watch

Bill Summary:
Would provide an alternative program to authorize a pharmacy to provide pharmacy services to covered entities, as defined, that are eligible for discount drug programs under federal law, as specified, through the use of an automated drug delivery system, as defined. This bill contains other related provisions and other existing laws.


 

AB 2086 - Controlled Substances: CURES Database (View Bill)
Bill Author
: James Gallagher
CSHP Position: Watch

Bill Summary:
Current law classifies certain controlled substances into designated schedules. Current law requires the Department of Justice to maintain the Controlled Substance Utilization Review and Evaluation System (CURES) for the electronic monitoring of the prescribing and dispensing of Schedule II, Schedule III, and Schedule IV controlled substances by a health care practitioner authorized to prescribe, order, administer, furnish, or dispense a Schedule II, Schedule III, or Schedule IV controlled substance. This bill would allow prescribers to access the CURES database for a list of patients for whom that prescriber is listed as a prescriber in the CURES database.


 

AB 2138 - Licensing Boards: Denial of Application: Revocation or Suspension of Licensure: Criminal Conviction (View Bill)
Bill Author
: David Chiu
CSHP Position: Watch

Bill Summary:
Current law requires a board to develop criteria to aid it when considering the denial, suspension, or revocation of a license to determine whether a crime is substantially related to the qualifications, functions, or duties of the business or profession the board regulates and requires a board to develop criteria to evaluate the rehabilitation of a person when considering the denial, suspension, or revocation of a license. This bill would revise and recast those provisions to instead authorize a board to, among other things, deny, revoke, or suspend a license on the grounds that the applicant or licensee has been convicted of a crime only if the applicant or licensee is presently incarcerated or if the conviction, as defined, occurred within the preceding 5 years, except for violent felonies.


 

AB 2174 - Controlled Substances: CURES Database (View Bill)
Bill Author
: Marie Waldron
CSHP Position: Support if Amended

Bill Summary:
Would require the State Department of Public Health, in consultation with stakeholders, to develop, coordinate, implement, and oversee a comprehensive multicultural public awareness campaign, to be known as “Heroin and Opioid Public Education (HOPE),” upon appropriation by the Legislature or receipt of state or federal grant funding, until January 1, 2023.


 

AB 2256 - Law Enforcement Agencies: Opioid Antagonist (View Bill)
Bill Author
: Miguel Santiago
CSHP Position: Support if Amended

Bill Summary:
Current law, the Pharmacy Law, provides for the licensure and regulation of pharmacies and wholesalers by the California State Board of Pharmacy within the Department of Consumer Affairs. Current law authorizes a pharmacy to furnish naloxone hydrochloride or other opioid antagonists to a school district, county office of education, or charter school if specified criteria are met.This bill would authorize a pharmacy or wholesaler to furnish naloxone hydrochloride or other opioid antagonists to a law enforcement agency, as provided.



AB 2277 - Solid Waste Facilities: Home-generated Pharmaceutical Waste: Incineration (View Bill)
Bill Author
: Devon Mathis
CSHP Position: Watch

Bill Summary:
Would vest the Department of Resources Recycling and Recovery with the primary responsibility for the disposal of home-generated pharmaceutical waste and, on or before January 1, 2020, would require the Department of Resources Recycling and Recovery, in collaboration with the State Department of Public Health, the Department of Toxic Substances Control, and the California State Board of Pharmacy, to adopt regulations authorizing the incineration of home-generated pharmaceutical waste by solid waste facilities, as specified.


 

AB 2384 - Medication-assisted Treatment (View Bill)
Bill Author
: Joaquin Arambula
CSHP Position: Support

Bill Summary:
Would require a drug formulary maintained by a health care service plan, including a Medi- Cal managed plan, or health insurer to include, at a minimum, specified prescription drugs for the medication-assisted treatment, as defined, of substance abuse disorders. The bill would provide that medication-assisted treatment is presumed to be medically necessary, and is not subject to specified requirements of a health care service plan or policy of health insurance, including prior authorization and an annual or lifetime dollar limit.



AB 2486 - Medi-Cal Opioid Prevention and Rehabilitation Act (View Bill)
Bill Author
: Kevin McCarty
CSHP Position: Watch

Bill Summary:
An act to add Article 3.3 (commencing with Section 14124.50) to Chapter 7 of Part 3 of Division 9 of the Welfare and Institutions Code, relating to Medi-Cal.



AB 2487 - Physicians and Surgeons: Education: Opiate-dependent Patient Treatment and Management (View Bill)
Bill Author
: Kevin McCarty
CSHP Position: Watch

Bill Summary:
An act to amend Section 2082 of, and to add Section 2190.6 to, the Business and Professions Code, relating to healing arts.



AB 2576 - Emergencies: Healthcare (View Bill)
Bill Author
: Cecilia Aguiar-Curry
CSHP Position: Support

Bill Summary:
Would authorize the Governor, during a state of emergency, to direct all state agencies to utilize, employ, and direct state personnel, equipment, and facilities for the performance of any and all activities that are designed to allow community clinics and health centers to provide and receive reimbursement for services provided during or immediately following the emergency. The bill would authorize any agency directed by the Governor to perform those activities to expend any of the moneys that have been appropriated to it in order to perform those activities, irrespective of the particular purpose for which the money was originally appropriated.



AB 2624 - Prescriptions (View Bill)
Bill Author
: Bill Brough
CSHP Position: Watch

Bill Summary:
The Pharmacy Law provides for the licensure and regulation of pharmacists and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs, and authorizes a pharmacist filling a prescription order for a drug product prescribed by its brand or trade name to select another drug product with the same active chemical ingredients of the same strength, quantity, and dosage form, and of the same generic drug name of those drug products having the same active chemical ingredients, as specified.This bill would make a nonsubstantive change to that provision.



AB 2653 - Health Care Coverage: Prescriptions (View Bill)
Bill Author
: Travis Allen
CSHP Position: Watch

Bill Summary:
Would require a specified health care service plan contract or individual or small group health insurance policy that covers outpatient prescription drug benefits with coverage for naltrexone or acamprosate to provide coverage for those 2 drugs if prescribed by a licensed health care professional. Because a willful violation of the bill’s requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.



AB 2741 - Prescription Drugs: Opioid Medications: Minors (View Bill)
Bill Author
: Autumn Burke
CSHP Position: Watch

Bill Summary:
Would prohibit a prescriber, as defined, from prescribing more than a 5-day supply of opioid medication to a minor unless the prescription is for specified uses. The bill would also require a prescriber to take certain steps before prescribing a minor a course of treatment with opioid medication, including discussing opioid risks and obtaining specified written consent, except in specified instances. The bill would make a violation of the bill’s provisions unprofessional conduct and would subject the prescriber to discipline by the board charged with regulating his or her license. The provisions of the bill requiring the prescriber to assess whether the minor has or is taking prescription drugs for treatment of a substance use disorder, discuss opioid risks, and obtain written consent would not apply until the development of a consent form by the Medical Board of California.



AB 2760 - Prescription Drugs: Naloxone Hydrochloride (View Bill)
Bill Author
: Jim Wood
CSHP Position: Support if Amended

Bill Summary:
Would require a prescriber, as defined, to prescribe naloxone hydrochloride for patients when certain conditions are present and to provide specified education to those patients and their households. The bill would make a violation of the bill’s provisions unprofessional conduct and would subject the prescriber to discipline by the board charged with regulating his or her license.



AB 2783 - Controlled Substances: Hydrocodone Combination Products: Schedules (View Bill)
Bill Author
: Patrick O'Donnell
CSHP Position: Watch

Bill Summary:
Would define controlled substances for the purposes of California law as any of the substances listed on the California and federal schedules, including substances that have been added to the federal schedules in regulations. The bill would provide that when the state and federal controlled substances schedules conflict, the schedule that is more closely regulated shall control. By expanding the definition of a crime, this bill would impose a state-mandated local program.



AB 2789 - Health Care Practitioners: Prescriptions: Electronic Data Transmission (View Bill)
Bill Author
: Jim Wood
CSHP Position: Support if Amended

Bill Summary:
Current law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. The Pharmacy Law provides that a prescription is an oral, written, or electronic data transmission order and requires electronic data transmission prescriptions to be transmitted and processed in accordance with specified requirements.This bill, on and after January 1, 2020, would require health care practitioners authorized to issue prescriptions to have the capability to transmit electronic data transmission prescriptions, and would require pharmacies to have the capability to receive those transmissions.



AB 2859 - Pharmacy: Safe Storage Products (View Bill)
Bill Author
: Anna Caballero
CSHP Position: Watch

Bill Summary:
Would require a chain community pharmacy or an independent community pharmacy that dispenses Schedule II, III, or IV controlled substances to display safe storage products within the pharmacy department. The bill would require the board to assess a fine against a pharmacy for violation of these provisions, except that the bill would allow the board to choose not to take administrative action against a pharmacy if the board determines that compliance with the law would create a financial hardship on the pharmacy. The bill would specify that a violation of these provisions shall not be punishable as a misdemeanor. The bill would also define certain terms for these purposes.



AB 2863 - Health Care Coverage: Prescriptions (View Bill)
Bill Author
: Adrian Nazarian
CSHP Position: Watch

Bill Summary:
An act to add Section 1367.47 to the Health and Safety Code, and to add Section 10123.65 to the Insurance Code, relating to health care coverage.



AB 2874 - Health Facilities: Notice: Attorney General (View Bill)
Bill Author
: Tony Thurmond
CSHP Position: Watch

Bill Summary:
Current law requires a hospital that provides emergency medical services to, as soon as possible, but not later than 90 days prior to a planned reduction or elimination of the level of emergency medical services, provide notice of the intended change to the department, other specified entities, and the public. Current law requires a health facility implementing a downgrade or change to make reasonable efforts to ensure that the community it serves is informed of the downgrade or closure. Current law also requires a health facility to provide public notice, as specified, not less than 30 days prior to closing the facility, eliminating a supplemental service, as defined, or relocating the provision of supplemental services to a different campus. This bill would require a hospital that provides emergency medical services or a health facility to provide notice, as specified, at least 180 days before making the changes described above.


 

AB 2941 - Health Care Coverage: State of Emergency (View Bill)
Bill Author
: Marc Berman
CSHP Position:Support

Bill Summary:
Would require a health care service plan or health insurer to ensure its enrollees or insureds who have been displaced by a state of emergency, as defined, have continued appropriate access to medically necessary health care services, as specified. Because a willful violation of the bill’s requirements relative to health care service plans would be a crime, the bill would impose a state mandated local program.



AB 3184 - California State Board of Optometry (View Bill)
Bill Author
: Blanca Rubio
CSHP Position: Watch

Bill Summary:
Current law, the Optometry Practice Act, establishes the State Board of Optometry within the Department of Consumer Affairs for purposes of licensing and regulating the practice of optometry. This bill would rename the State Board of Optometry as the California State Board of Optometry.


 

SB 17 - Health Care: Prescription Drug Costs (View Bill)
Bill Author
: Sen. Ed Hernandez
CSHP Position: Chapterted (Prev. Support)

Bill Summary:
Current law requires health care service plans and health insurers to file specified rate information with DMHC or DOI, as applicable, for health care service plan contracts or health insurance policies in the individual or small group markets and for health care service plan contracts and health insurance policies in the large group market. This bill would require health care service plans or health insurers that file the above-described rate information to report to DMHC or DOI, on a date no later than the reporting of the rate information, specified cost information regarding covered prescription drugs, including generic drugs, brand name drugs, and specialty drugs, dispensed as provided.


 
 

SB 43 -  Antimicrobial-resistant Infection: Reporting (View Bill)
Bill Author: Sen. XXXX Hill
CSHP Position: Watch

Bill Summary:
Would require specified general acute care hospitals and clinical laboratories to submit a report to the Department of Public Health , commencing July 1, 2019, and each July 1 thereafter, containing an antibiogram of the facility for the previous year. The bill would require the Antimicrobial Stewardship and Resistance Subcommittee of the Healthcare Associated Infections Advisory Committee of the department, on or before January 1, 2019, to develop and recommend to the department, the acceptable electronic format for the report and a method for the department to accurately estimate the number of deaths that result from antimicrobial resistant infections for specified types of antimicrobial infections.


 

SB 176 - Controlled Substances: Fentanyl and Carfentanil (View Bill)
Bill Author
: Sen. Pat Bates
CSHP Position: Dead (Prev. Support)

Bill Summary:
Current law classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The drug fentanyl, an opiate, is classified in Schedule II. Current law prohibits a person from possessing for sale or purchasing for purposes of sale specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision. This bill would classify carfentanil, an opiate, in Schedule II.


 

SB 199 -  The California Health Care Cost, Quality, and Equity Atlas (View Bill)
Bill Author: Sen. Ed Hernandez
CSHP Position: Watch

Bill Summary:
Would require the Secretary of California Health and Human Services, in furtherance of the goal of creating the California Health Care Cost, Quality, and Equity Atlas, to convene an advisoryPage 7/11 goal of creating the California Health Care Cost, Quality, and Equity Atlas, to convene an advisory committee composed of a broad spectrum of health care stakeholders and experts, as specified. The bill would require the secretary to charge the advisory committee with identifying the type of data, purpose of use, and entities and individuals that are required to report to, or that may have access to, a health care cost, quality, and equity atlas, and with developing a set of recommendations based on specified findings of the March 1, 2017, report.


 

SB 212 -  Medical Waste (View Bill)
Bill Author: Sen. Hannah-Beth Jackson
CSHP Position: Watch

Bill Summary:
Current law, the Medical Waste Management Act, administered by the State Department of Public Health, regulates the management and handling of medical waste, as defined.This bill add to the act a definition of “home-generated pharmaceutical waste” as a prescription or over-the-counter human or veterinary home-generated pharmaceutical that is waste and is derived from a household, including, but not limited to, a multifamily residence or household.


 

SB 320 -  Public Health: Public Postsecondary Education: On-campus Student Health Centers: Abortion by Medication Techniques (View Bill)
Bill Author: Sen. Connie Levya
CSHP Position: Watch

Bill Summary:
Current law establishes the University of California, under the administration of the Regents of the University of California, and the California State University, under the administration of the Trustees of the California State University, as 2 of the segments of public postsecondary education in this state. This bill would express findings and declarations of the Legislature relating to the availability of abortion by medication techniques at on-campus student health centers at public postsecondary educational institutions in the state.


 

 

SB 351 - Hospital Satellite Compounding Pharmacy License Requirements (View Bill)
Bill Author
: Sen. Richard Roth
CSHP Position: Chaptered (Prev. Support)

Bill Summary:
Under current law, a hospital pharmacy means and includes a pharmacy, licensed by the board, located within any licensed hospital that maintains and operates organized facilities for the diagnosis, care, and treatment of human illnesses to which persons may be admitted for overnight stay and that meets specified requirements. A hospital pharmacy also includes a pharmacy that may be located outside of the hospital in another physical plant that is regulated under a hospital’s consolidated license as a general acute care hospital that includes more than one physical plant maintained and operated on separate premises or that has multiple licenses for a single health facility on the same premises. With respect to a hospital pharmacy located outside of the hospital in another physical plant, this bill would redefine a “hospital pharmacy” to include a pharmacy that is located in any physical plant that is regulated as a general acute care hospital.


 

SB 419 -  Medical Practice: Pain Management (View Bill)
Bill Author: Sen. Anthony Portantino
CSHP Position: Watch

Bill Summary:
Would require a specified health care practitioner, before prescribing, ordering, or furnishing specified narcotic pain medications, including controlled substances, to a minor, as defined, to educate the guardian of the minor on all other available medical treatments, specified nonopioid treatment alternatives to be tried before and alongside opioid therapy, the risks and benefits of narcotic medications and alternatives to narcotic medications, the safe storage of opioid medications, the proper disposal of unused medications, and the illegality of sharing or misusing prescribed medications.


 

SB 433 - Pharmacy Emergency Medical Services Automated Drug Delivery System (View Bill)
Bill Author
: Sen. Ed Hernandez
CSHP Position: Support if amended

Bill Summary:
Would authorize a pharmacy or licensed wholesaler that is also an emergency medical services provider agency to restock dangerous drugs or dangerous devices into an emergency medical services automated drug delivery system, as defined, that is licensed by the California State Board of Pharmacy if specified conditions are met, including that the emergency medical services provider agency obtain a license from the board to operate the system, and requires dangerous drugs and dangerous devices stored or maintained in an emergency medical services automated drug delivery system to be used for the sole purpose of restocking a secured emergency pharmaceutical supplies container.


 

SB 510 - Pharmacies: Compounding (View Bill)
Bill Author
: Sen. Jeff Stone
CSHP Position: Chaptered (Prev. Support)

Bill Summary:
Under the Pharmacy Law, the California State Board of Pharmacy licenses and regulates the practice of pharmacy by pharmacists and pharmacy corporations in this state. That law prohibits a pharmacy from compounding sterile drug products unless the pharmacy has obtained a sterile compounding pharmacy license from the board. That law requires a pharmacy to compound sterile products from one or more nonsterile ingredients in prescribed environments. This bill would repeal that compounding environment provision and make conforming renumbering changes to other provisions.


 

SB 528 -  Pharmacy: Automated Drug Delivery Systems (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Watch

Bill Summary:
The Pharmacy Law authorizes a pharmacy to provide pharmacy services to specified licensed health facilities through the use of an automated drug delivery system. The Pharmacy Law authorizes a licensed clinic to make use of an automated drug delivery system, operated under the supervision of a pharmacist, but under the clinic’s license and under which the clinic is responsible for the safety and security of the drugs in the system. This bill would provide an alternative program to authorize a pharmacy to provide pharmacy services to clinics that qualify as covered entities that are eligible for discount drug programs under federal law, as specified, through the use of an automated drug delivery system, as defined.


 

SB 562 -  The Healthy California Act (View Bill)
Bill Author: Sen. Ricardo Lara
CSHP Position: Watch

Bill Summary:
Current law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. This bill, the Healthy California Act, would create the Healthy California program to provide comprehensive universal single-payer health care coverage and a health care cost control system for the benefit of all residents of the state.


 

SB 641 -  Controlled Substance Utilization Review and Evaluation System: Privacy (View Bill)
Bill Author: Sen. Ricardo Lara
CSHP Position: Watch

Bill Summary:
Under current law, data obtained from CURES may only be provided to appropriate state, local, and federal public agencies for disciplinary, civil, or criminal purposes and to other agencies or entities, as determined by the Department of Justice, for the purpose of educating practitioners and Page 10/11 others in lieu of disciplinary, civil, or criminal actions. Current law allows data obtained from CURES to be provided to public or private entities for statistical or research purposes, as approved by the department. This bill would prohibit the release of data obtained from CURES to a law enforcement agency except pursuant to a warrant based on probable cause, as specified.


 

SB 716 - California State Board of Pharmacy: Pharmacy Technician Member (View Bill)
Bill Author
: Sen. Ed Hernandez
CSHP Position: Support (CSHP Sponsored Legislation)
View CSHP SB 716 Webpage

Bill Summary:
This bill would increase the number of members of the California State Board of Pharmacy to 15 by adding one pharmacy technician appointed by the Governor and one additional public member appointed by the Governor. The bill would require the pharmacy technician board member to have at least 5 years of experience and to continue to work in California as a pharmacy technician. The bill would require the pharmacy technician board member to have specified work experience as a pharmacy technician and to have documented work experience in a variety of pharmacy procedures and practices, as specified.


 

SB 790 -  Health Care Providers: Gift and Benefits (View Bill)
Bill Author: Sen. Mike McGuire
CSHP Position: Watch

Bill Summary:
Would, on and after January 1, 2019, prohibit a manufacturer of a prescribed product from offering or giving a gift to a health care provider. The bill would further prohibit a manufacturer of a prescribed product or an entity on behalf of a manufacturer of a prescribed product from providing a fee, payment, subsidy, or other economic benefit to a health care provider in connection with the provider’s participation in research, except as specified. The bill would define terms of its purposes, including, among others, the term “gift.” The bill would specify circumstances to which these prohibitions do not apply.


 

SB 1021 -  Prescription Drugs (View Bill)
Bill Author: Sen. Connie Levya
CSHP Position: Watch

Bill Summary:
Current law prohibits the formulary or formularies for outpatient prescription drugs maintained by a health care service plan or health insurer from discouraging the enrollment of individuals with health conditions and from reducing the generosity of the benefit for enrollees or insureds with a particular condition. Current law, until January 1, 2020, provides that the copayment, coinsurance, or any other form of cost sharing for a covered outpatient prescription drug for an individual prescription shall not exceed $250 for a supply of up to 30 days, except as specified. Existing law, until January 1, 2020, requires a nongrandfathered individual or small group plan contract or policy to use specified definitions for each tier of a drug formulary. This bill would extend those provisions indefinitely.



SB 1109 -  Controlled Substances: Schedule II Drugs: Opioids (View Bill)
Bill Author: Sen. Patricia Bates
CSHP Position: Oppose Unless Amended

Bill Summary:
Would require, for physicians and surgeons licensed on or after January 1, 2019, the mandatory continuing education course to also include the subject of the risks of addiction associated with the use of Schedule II drugs. The bill would require the board to give its highest priority to considering a course in the risks of addiction associated with the use of Schedule II drugs among its continuing education requirements for physicians and surgeons and would require the board to periodically develop and disseminate information and educational material on the risks of addiction associated with the use of Schedule II drugs to physicians and surgeons and general acute care hospitals.



SB 1229 -  Pharmacists: Opioid Medications: Consultation  (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Watch

Bill Summary:
This bill, except as specified, would require a pharmacist, on dispensing any opioid medication to a patient or the patient’s agent for the first time, to provide oral consultation before dispensing the medication, in accordance with regulations to be adopted by the California State Board of Pharmacy. The bill would prohibit the pharmacist from dispensing the medication if the patient or the patient’s agent declines the consultation. Because a knowing violation of the bill’s provisions would be a crime, the bill would impose a state-mandated local program.



SB 1240 -  Prescription Drugs: CURES Database: Opioids (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Watch

Bill Summary:
Would require a prescription, if in writing or transmitted electronically, to include an International Statistical Classification of Diseases, 10th revision (ICD-10) Code or a legible clear notice of the condition or purpose for which the drug is being prescribed, unless the patient requests this information to be omitted and would require a prescription transmitted orally to include either an ICD- 10 Code of a description of the condition or purpose for which the drug is being prescribed.



SB 1254 -  Hospital Pharmacies: Medication Profiles or Lists for High-risk Patients (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Support if Amended

Bill Summary:
Would require a pharmacist at a hospital pharmacy to obtain an accurate medication profile Page 10/14 or list for each high-risk patient upon admission and discharge of the patient. The bill would authorize an intern pharmacist or a pharmacy technician to perform the task of obtaining an accurate medication profile or list for a high-risk patient if certain conditions are satisfied. The bill would require the hospital to determine what constitutes a high-risk patient for purposes of the bill’s provisions based on the populations served by the hospital.



SB 1264 -  Medi-Cal: Hypertension Medication Management Services: Advanced Practice Pharmacists (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Sponsor
CSHP SB 1264 Webpage

Bill Summary:
Would authorize an advanced practice pharmacist to provide hypertension medication management services, as defined, to Medi-Cal beneficiaries. The bill would authorize a pharmacist providing hypertension medication management services to access the state health information exchange and any relevant continuity of care documents maintained by a health facility, subject to applicable federal and state privacy and confidentiality laws. This bill would include hypertension medication management services as a covered pharmacist service under the Medi-Cal program.



SB 1285 -  Health Care Coverage: Advanced Practice Pharmacist (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Support if Amended

Bill Summary:
Would require coverage for services provided by an advanced practice pharmacist, as defined, performed within the scope of his or her practice, including, but not limited to, comprehensive medication management (CMM) services, as defined, in a health care service plan contract and health insurance policy, and, to the extent that federal financial participation is available, in a Medi-Cal managed care plan. Because a willful violation of that provision by a health care service plan would be a crime, the bill would impose a state-mandated local program.



SB 1286 -  Pharmacy Technicians  (View Bill)
Bill Author: Sen. Richard Pan
CSHP Position: Oppose

Bill Summary:
The Pharmacy Law authorizes a pharmacy technician to perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. That law makes a pharmacist responsible for the duties performed under his or her supervision by a technician and allows a pharmacy with only one pharmacist to have only one pharmacy technician performing those tasks. This bill would allow a pharmacy with only one pharmacist to have no more than 4 pharmacy technicians performing those tasks.



SB 1322 -  Medi-Cal: Comprehensive Medication Management (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Watch

Bill Summary:
Current law provides for a schedule of benefits under the Medi-Cal program, which includes outpatient prescription drugs, subject to utilization controls and the Medi-Cal list of contract drugs. This bill would provide that comprehensive medication management (CMM) services, as defined, are a covered benefit under the Medi-Cal program, and would require those services to include, among other things, the development and implementation of a written medication treatment plan that is designed to resolve documented medication therapy problems and to prevent future medication therapy problems.



SB 1373 -  General Acute Care Hospitals: Minimum Levels of Pharmaceutical Staff (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Watch

Bill Summary:
Would require a general acute care hospital licensed by the State Department of Public Health to employ, at a minimum, one full-time pharmacist for every 100 licensed beds, and for additional licensed beds, employ additional pharmacists on a pro rata basis. The bill would require a general acute care hospital that is licensed for less than 100 beds to employ one pharmacist on at least a part-time basis.



SB 1404 -  Pharmacists: Exemption From Overtime Regulations (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Support if Amended

Bill Summary:
Would provide that a person employed in the practice of pharmacy, who is participating in a postgraduate training program, as specified, who is in a field relating to the practice of pharmacy or pharmacy research, or who is performing certain procedures or functions, is not subject to coverage under any provision of the orders of the Industrial Welfare Commission.



SB 1426 -  Pharmacists: Authority to Prescribe and Dispense Dangerous Drugs and Devices (View Bill)
Bill Author: Sen. Jeff Stone
CSHP Position: Support

Bill Summary:
Would require the California State Board of Pharmacy to convene a Public Health and Pharmacy Formulary Advisory Committee to advise the board in promulgating regulations to establish a formulary of drugs and devices that an advanced practice pharmacist may furnish to a patient. The bill would require the board to establish a formulary of dangerous drugs and devices that an advanced practice pharmacist may furnish to a patient, and would authorize an advanced practice pharmacist to furnish a dangerous drug or dangerous device included on the formulary to a patient pursuant to a diagnosis by a health care practitioner.



SB 1442 -  General Acute Care Hospitals: Minimum Levels of Pharmaceutical Staff (View Bill)
Bill Author: Sen. Scott Wiener
CSHP Position: Watch

Bill Summary:
Would prohibit a pharmacy from requiring a pharmacist to engage in the practice of pharmacy unless the pharmacist is assisted at all times by either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located.



SB 1447 -  Pharmacy: Automated Drug Delivery Systems: Licensing (View Bill)
Bill Author: Sen. Ed Hernandez
CSHP Position: Watch

Bill Summary:
Current law generally requires a pharmacy that owns or provides dangerous drugs dispensed through an automated drug delivery system (ADDS) to register the system, as provided, and authorizes the pharmacy to use the ADDS only if certain conditions are satisfied. This bill would repeal the general ADDS provisions. The bill instead would prohibit an ADDS unit from being installed or operated in the state unless specified requirements are met, including a license for the ADDS unit issued by the board to the holder of a current, valid, and active pharmacy license, and would require the pharmacy holding the license to complete periodic self-assessments.



SB 1448 -  Healing Arts Licensees: Probation Status: Disclosure  (View Bill)
Bill Author: Sen. Jerry Hill
CSHP Position: Watch

Bill Summary:
Would, on and after July 1, 2019, require specified regulatory boards to require a licensee to provide a separate disclosure, as specified, to a patient or a patient’s guardian or health care surrogate before the patient’s first visit if the licensee is on probation pursuant to a probationary order made on and after July 1, 2019. The bill would also require those regulatory boards to provide specified information relating to licensees on probation on the regulatory entity’s online license information web site.


 

Legislative Resources
Legend/Glossary Terms

Contacts

California Society of Health-System Pharmacists
1314 H Street, Suite 200
Sacramento, CA 95814
Office: (916) 447-1033
Fax: (916) 447-2396
Email: info@cshp.org
Hours: M-F 8:00am – 5:00pm

Connect